| 101805-0 | Bone DXA Calcaneus Bone density | RAD |
| 101806-8 | Amyloid beta 42 peptide/Amyloid beta 40 peptide (lc/ms/ms) | CHEM |
| 101807-6 | Malnutrition risk screen results indicator | NUTRITION&DIETETICS |
| 101808-4 | Xylazine (Urine, confirmatory method) | DRUG/TOX |
| 101809-2 | Xylazine (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 10181-6 | History of Urinary tract disorders Narrative | H&P.HX |
| 101810-0 | Xylazine/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101811-8 | 2,6-dimethylaniline (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 101812-6 | 2,6-dimethylaniline/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101813-4 | 2,6-dimethylaniline (Urine, confirmatory method) | DRUG/TOX |
| 101814-2 | BK virus DNA (viral load) (CSF, naa with probe detection) | MICRO |
| 101815-9 | Cytomegalovirus DNA (viral load) (CSF, naa with probe detection) | MICRO |
| 101816-7 | Cytomegalovirus DNA (viral load) (Urine, naa with probe detection) | MICRO |
| 101817-5 | Epstein Barr virus DNA (viral load) (CSF, naa with probe detection) | MICRO |
| 101818-3 | Herpes virus 6 DNA (CSF, naa with probe detection) | MICRO |
| 101819-1 | Nutritional assessment for malnutrition status | CLIN.RISK |
| 10182-4 | History of Travel note | H&P.HX |
| 101820-9 | Preimplantation targeted mutation analysis in Embryo (molecular genetics method) | MOLPATH.MUT |
| 101822-5 | Human papilloma virus cytology and high-risk genotypes panel - Cervix | PANEL.MICRO |
| 101823-3 | Apolipoprotein C-III (qualitative, isoelectric focusing) | CHEM |
| 101824-1 | Aspartylglucosaminidase | CHEM |
| 101825-8 | Calcium hydrogen phosphate dihydrate crystals in 24 hour Urine | CHEM |
| 101826-6 | Sodium Urate crystals in 24 hour Urine | CHEM |
| 101827-4 | Urate crystals in 24 hour Urine | CHEM |
| 101828-2 | Synthetic glucocorticoid panel - Serum or Plasma | PANEL.CHEM |
| 101829-0 | Tetrazepam | DRUG/TOX |
| 10183-2 | Hospital discharge medications Narrative | H&P.HX |
| 101830-8 | Medazepam | DRUG/TOX |
| 101831-6 | Beclomethasone dipropionate | CHEM |
| 101832-4 | Betamethasone | DRUG/TOX |
| 101833-2 | Budesonide | DRUG/TOX |
| 101834-0 | Dexamethasone | DRUG/TOX |
| 101835-7 | Fludrocortisone | DRUG/TOX |
| 101836-5 | Flunisolide | DRUG/TOX |
| 101837-3 | Fluorometholone | DRUG/TOX |
| 101838-1 | Fluticasone propionate | DRUG/TOX |
| 101839-9 | Megestrol acetate | DRUG/TOX |
| 10184-0 | Hospital discharge physical findings Narrative | H&P.HX |
| 101840-7 | Methylprednisolone | DRUG/TOX |
| 101841-5 | prednisoLONE | DRUG/TOX |
| 101843-1 | Triamcinolone | DRUG/TOX |
| 101844-9 | Triamcinolone acetonide | DRUG/TOX |
| 101845-6 | Sweat analysis specialist review of results | CHEM |
| 101846-4 | Beclomethasone dipropionate (Urine) | DRUG/TOX |
| 101847-2 | Betamethasone (Urine) | DRUG/TOX |
| 101848-0 | Budesonide (Urine) | DRUG/TOX |
| 101849-8 | Dexamethasone (Urine) | DRUG/TOX |
| 10185-7 | Hospital discharge procedure note | H&P.HX |
| 101850-6 | Fludrocortisone (Urine) | DRUG/TOX |
| 101851-4 | Flunisolide (Urine) | DRUG/TOX |